Dr. Ashish Kumar Aggarwal, MD

Dr. Aggarwal practices at Providence Cedars-Sinai Tarzana Medical Center in Tarzana, California, part of Providence Health & Services.

Dr. Aggarwal's NPI, 1760682868, was assigned on July 18, 2007. Dr. Aggarwal graduated from Keck School of Medicine of USC in 2007. Dr. Aggarwal's California license number on file is A131211.

Dr. Aggarwal's primary practice is Providence Cedars-Sinai Tarzana Medical Center, at 18321 Clark Street, Tarzana, CA 91356 in Los Angeles County. The practice phone is (818) 881-0800.

Dr. Aggarwal's primary practice is Providence Cedars-Sinai Tarzana Medical Center in Tarzana, California, part of Providence Health & Services. The medical group on file is Cardiovascular Consultants Medical Group. Dmand AI also links Dr. Aggarwal to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aggarwal practices, 4 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Aggarwal's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Aggarwal is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Aggarwal's licenses on file in 3 states: California, Michigan and Indiana.

Dmand AI lists aneurysm, angioplasty, aortic atherosclerois, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease and chronic hypertension among the conditions Dr. Aggarwal treats.

CMS data shows 1,899 Medicare services from Dr. Aggarwal across 31 procedure codes in 2024, for 610 Medicare patients. Medicare paid $238,754 for them.

CMS counts 610 Medicare patients who saw Dr. Aggarwal in 2024. The largest group is 75 to 84, with 252 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 35% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Aggarwal's median patient age at 72, with 46% women.

In 2024, Dr. Aggarwal wrote 2,447 Medicare Part D claims for 404 patients. 79% of them were for generic drugs. CMS names the drug for 2,229 of them, across 34 drugs with 11 or more claims each, at $487,890 in total drug cost. In 2023, CMS named 1,942 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Aggarwal for performance year 2024, reported individually. Dr. Aggarwal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 110 general payments to Dr. Aggarwal from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbott Laboratories paid the most, $3,044.

Dr. Aggarwal graduated from Keck School of Medicine of USC in 2007. Dr. Aggarwal is a member of ACC.

Dr. Aggarwal is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.